StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis IFRS Diluted EPS by Quarter

IFRS Diluted EPS (USD/share) ($)

QuarterlyAnnual

Novartis IFRS Diluted EPS: $0.63 in Q3 2026, down 68.8% from a year earlier.

Latest, Q3 2026
0.63
Period ended Sep 30, 2026
Change on a year earlier
-68.8%
2.02 in Q3 2025
History
37 quarters
Since Q2 2017
Sources
33
Documents cited below

Where the Q3 2026 figure comes from

“|| Diluted earnings per share (USD) 1 | 0.63 | 2.02”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Postgres DB + Form 6-K.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedIFRS Diluted EPS (USD/share) ($)Year on yearSource
Q3 2026Sep 30, 20260.63-68.8%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 20261.71-17.0%Novartis 6-K (0001114448-26-000012, filed 2026-07-21) ↗
Q1 2026Mar 31, 20261.65-9.3%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 20251.25-11.3%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 20252.02+28.7%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 20252.06+29.6%Novartis 6-K (0001370368-25-000012, filed 2025-07-17) ↗
Q1 2025Mar 31, 20251.82+38.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 20241.41+10.2%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 20241.57+115.1%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 20241.59+43.2%Novartis 6-K (0001370368-24-000019, filed 2024-07-18) ↗
Q1 2024Mar 31, 20241.31+29.7%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 20231.28+109.8%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 20230.73+19.7%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 20231.11+44.2%Novartis 6-K (0001370368-23-000059, filed 2023-07-18) ↗
Q1 2023Mar 31, 20231.01+2.0%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 20220.61-91.6%Novartis Form 6-K (0001370368-24-000007) ↗

Cite this data

StockData. (2026). Novartis IFRS Diluted EPS ($), quarterly Q2 2017–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-is-eps-diluted

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.